Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Faster, Cleaner, Better.

Yew Bio-Pharm Group Inc (YEWB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	12-2019	12-2018	12-2017	12-2016
Cash Flows From Operating Activities
Net Income	1,465	986	-1,322	3,213	2,007
Depreciation Amortization	2,817	1,827	755	3,747	8,931
Accounts receivable	-776	-1,689	18,511	-8,554	-12,260
Accounts payable and accrued liabilities	-114	-120	-236	-2,933	3,435
Other Working Capital	2,291	2,742	12,822	-10,290	-12,826
Other Operating Activity	11,657	8,208	1,937	12,196	11,357
Operating Cash Flow	$17,340	$11,954	$32,467	$-2,620	$643

Cash Flows From Investing Activities
PPE Investments	-4,649	-13	-44	N/A	-62
Purchase Sale Intangibles	-12,707	-14,656	-32,757	-799	N/A
Other Investing Activity	-12,707	-14,656	-32,757	-799	296
Investing Cash Flow	$-17,356	$-14,669	$-32,800	$-799	$235

Cash Flows From Financing Activities
Change In Short Term Borrowing	11,814	11,905	9,013	10,940	1,809
Debt Issued	106	89	N/A	N/A	0
Debt Repayment	N/A	-30	N/A	N/A	-49
Common Stock Issued	N/A	N/A	40	N/A	N/A
Other Financing Activity	-11,934	-9,060	-9,027	-7,016	-3,022
Financing Cash Flow	$-15	$2,905	$26	$3,925	$-1,262

Exchange Rate Effect	-148	31	-31	76	-19
Beginning Cash Position	742	522	860	279	682
End Cash Position	564	742	522	860	279
Net Cash Flow	$-179	$221	$-338	$581	$-403

Free Cash Flow
Operating Cash Flow	17,340	11,954	32,467	-2,620	643
Capital Expenditure	-4,649	-26	-44	N/A	-62
Free Cash Flow	12,691	11,928	32,424	-2,620	582